Home-based Bimodal Lifestyle Intervention in Patients With Liver Cirrhosis Awaiting Orthotopic Liver Transplantation
FIT4Cirrhotics
FIT4Cirrhotics@Home: Effects of a Home-based Bimodal Lifestyle Intervention in Patients With Liver Cirrhosis Awaiting Orthotopic Liver Transplantation
1 other identifier
interventional
16
1 country
1
Brief Summary
Chronic liver disease eventually results in liver cirrhosis and is associated with an increasing deterioration in patients' physical fitness. As there is currently limited evidence regarding the effects of a home-based exercise program in patients with liver cirrhosis awaiting OLT, and physical frailty rates are particularly high in this patient population, this group has the investigators specific interest. The primary aim of this study is to assess the effect of a semi-supervised home-based bimodal lifestyle program, consisting of interval and endurance training and peripheral resistance training on aerobic capacity in patients with liver cirrhosis awaiting OLT
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2023
CompletedFirst Posted
Study publicly available on registry
May 10, 2023
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedMay 16, 2024
May 1, 2024
7 months
February 10, 2023
May 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Aerobic capacity
The main study parameter/endpoint is the change in aerobic capacity after the first six weeks of the FIT4Cirrhotics@Home program, for which the following outcomes will be assessed: VO2 at the VAT (ml/kg/min). A cardiopulmonary exercise test will be performed by participants to determine their aerobic capacity pre-intervention and after six weeks of training.
During baseline measurements patients will perform a cardiopulmonary exercise test to determine their baseline aerobic capacity. After 6 weeks of home-based training the cardiopulmonary exercise test will be repeated to reassess their aerobic capacity.
Secondary Outcomes (10)
Ultrasound measurements of muscle thickness
through study completion, an average of 1 year
Anthropometry assessment
through study completion, an average of 1 year
Functional mobility assessment
through study completion, an average of 1 year
Quality of Life assessment
through study completion, an average of 1 year
Perceived fatigue assessment
through study completion, an average of 1 year
- +5 more secondary outcomes
Study Arms (1)
Home based prehabilitation
EXPERIMENTALParticipants will be subjected to two training periods of six weeks (or until transplantation) of a semi-supervised home-based bimodal lifestyle program. The bimodal lifestyle program consists of an exercise program combined with nutritional support. The exercise program comprises high intensity interval training and endurance training, combined with peripheral resistance training and breathing exercises
Interventions
Participants will be subjected to two training periods of six weeks (or until transplantation) of a semi-supervised home-based bimodal lifestyle program. The bimodal lifestyle program consists of an exercise program combined with nutritional support. The exercise program comprises high intensity interval training and endurance training, combined with peripheral resistance training and breathing exercises
Eligibility Criteria
You may qualify if:
- Aged at least 18 years;
- Diagnosed with end-stage liver disease / liver cirrhosis (regardless of etiology);
- On the waiting list for OLT;
- VO2 at the VAT ≤13 ml/kg/min and/or VO2peak ≤18 ml/kg/min;
- Speaks the Dutch language;
- Understands the purpose of the study and has given written informed consent to participate in the study.
You may not qualify if:
- Experienced a MACE (e.g., myocardial infarction) in the past six months;
- Experienced a cerebrovascular incident in the past six months;
- Medical history of an uncontrolled heart rhythm disorder;
- Hepatic encephalopathy grade 3 or 4;
- Acute liver failure;
- Acute on chronic liver failure;
- Hospitalization at start of the study;
- Non-treated esophageal varices (i.e., variceal eradication endoscopy and/or adequately dosed NSBB);
- MELD score ≥30;
- Not capable of cycling on a cycle ergometer;
- No available community physical therapist in the living area of the patient.
- Patients refusing or unable to sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Groningen
Groningen, 9713 GZ, Netherlands
Related Publications (1)
Wijma AG, Bongers BC, Annema C, Dekker R, Blokzijl H, van der Palen JA, De Meijer VE, Cuperus FJ, Klaase JM. 'Effects of a home-based bimodal lifestyle intervention in frail patients with end-stage liver disease awaiting orthotopic liver transplantation': study protocol of a non-randomised clinical trial. BMJ Open. 2024 Jan 29;14(1):e080430. doi: 10.1136/bmjopen-2023-080430.
PMID: 38286689DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2023
First Posted
May 10, 2023
Study Start
September 1, 2024
Primary Completion
April 1, 2025
Study Completion
August 1, 2025
Last Updated
May 16, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share